In a Time of Crisis: Dr. Amanda Rischbieth on Blood Donation, Solidarity, and Saving Lives
Dr Amanda Rischbieth, Harvard Advanced Leadership Advisory Board at Harvard University, shared a post on LinkedIn:
“With my Chair of the National Blood Authority, Australia hat on, I thank the thousands who have stepped up without hesitation.
As of 1pm today, Australian Red Cross Lifeblood service has seen 20,000 appointments booked nationally and many waited up to 5hr to give blood.
So much healing ahead yet we are seeing such unwaivering spirit, love and support for those impacted yesterday at Bondi, in Sydney.
My heartfelt condolences to those who have lost loved ones, those who are injured, and the entire Jewish community in Sydney and beyond.
O negative and O positive blood are always in high demand because they are used in emergency situations when a patient’s blood type is unknown.
Fewer than 7% of the population are O negative so in particular we need O negative donors to donate.
With gratitude to all donors and emergency responders/hospital workers/blood donation teams, and NBA workers side by side with Red Cross in moving blood to where its most needed and fast ramping up donation capability.”
Get the latest hemostasis insights on Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis